tolvaptan has been researched along with Cardiovascular Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajioka, M; Iwao, T; Saito, M; Suzuki, T | 1 |
| Maggioni, AP | 1 |
| Kamyar, M; Lemmens-Gruber, R | 1 |
| Shoji, M; Yasujima, M | 1 |
2 review(s) available for tolvaptan and Cardiovascular Diseases
| Article | Year |
|---|---|
Vasopressin antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Binding Sites; Cardiovascular Diseases; Clinical Trials as Topic; Hormone Antagonists; Humans; Indoles; Pyrroles; Pyrrolidines; Tolvaptan; Vasopressins; Water-Electrolyte Imbalance | 2006 |
[Recent progress in vasopressin research on cardiovascular diseases].
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Biomarkers; Cardiovascular Diseases; Humans; Platelet Aggregation; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Receptors, Vasopressin; Tolvaptan | 2007 |
2 other study(ies) available for tolvaptan and Cardiovascular Diseases
| Article | Year |
|---|---|
Enhancement of Warfarin Anticoagulant Reaction in Patients with Repeated Oral Tolvaptan Administration.
Topics: Administration, Oral; Anticoagulants; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiovascular Diseases; Drug Interactions; Drug Therapy, Combination; Female; Humans; International Normalized Ratio; Male; Prothrombin Time; Retrospective Studies; Tolvaptan; Warfarin | 2018 |
[Multination clinical trials: what is the relevance and what are the lessons from across-country differences?].
Topics: Acute Coronary Syndrome; Adenosine; Americas; Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Ethnicity; Europe; Female; Georgia (Republic); Heart Failure; Humans; Internationality; Male; Metoprolol; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Russia; Sample Size; Spironolactone; Ticagrelor; Ticlopidine; Tolvaptan | 2014 |